BRI Pharmaceutical Research Inc.
Unit 101, 8898 Heather Street
Member Sector: Contract Research and Scientific Services
For more than two decades, BRI has assisted hundreds of biotech and pharmaceutical companies on their pre-clinical and clinical development programs.
Being one of the few privately owned CRO with capabilities in bioanalytical, in vivo and in vitro DMPK and xenograft animal models in Western Canada, BRI’s uncompromising study protocols, stringent quality control measures, and relevant study design allows them to build trusted and long lasting partnerships with their highly valued clients.